Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
53.8M
-
Shares change
-
+49.5M
-
Total reported value, excl. options
-
$908M
-
Value change
-
+$834M
-
Put/Call ratio
-
0.62
-
Number of buys
-
63
-
Number of sells
-
-11
-
Price
-
$16.82
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2018
92 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2018.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.8M shares
.
Largest 10 shareholders include UBS Group AG (10.1M shares), BANK OF AMERICA CORP /DE/ (6.9M shares), CITIGROUP INC (6.55M shares), GOLDMAN SACHS GROUP INC (5.1M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (3.77M shares), NORTHERN TRUST CORP (3.41M shares), Mondrian Investment Partners LTD (2.87M shares), CAUSEWAY CAPITAL MANAGEMENT LLC (2.2M shares), Parametric Portfolio Associates LLC (1.54M shares), and CREDIT SUISSE AG/ (1.37M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.